Related Experiment Video
Updated: Apr 1, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes
Mohammad Shahidul Makki1, Tariq M Haqqi1
1Department of Anatomy and Neurobiology, Northeast Ohio Medical University, Rootstown, OH USA.
Abstract:
IL-6 is an inflammatory cytokine and its overexpression plays an important role in osteoarthritis (OA) pathogenesis. Expression of IL-6 is regulated post-transcriptionally by MCPIP1. The 3' untranslated region (UTR) of MCPIP1 mRNA harbors a miR-139 'seed sequence', therefore we examined the post-transcriptional regulation of MCPIP1 by miR-139 and its impact on IL-6 expression in OA chondrocytes. Expression of miR-139 was found to be high in the damaged portion of the OA cartilage compared with unaffected cartilage from the same patient and was also induced by IL-1β in OA chondrocytes. Inhibition of miR-139 decreased the expression of IL-6 mRNA by 38% and of secreted IL-6 protein by 40%. However, overexpression of miR-139 increased the expression of IL-6 mRNA by 36% and of secreted IL-6 protein by 56%. These data correlated with altered expression profile of MCPIP1 in transfected chondrocytes. Studies with a luciferase reporter construct confirmed the interactions of miR-139 with the 'seed sequence' located in the 3' UTR of MCPIP mRNA. Furthermore, miR-139 overexpression increased the catabolic gene expression but expression of anabolic markers remained unchanged. Overexpression of miR-139 also induced apoptosis in OA chondrocytes. Importantly, we also discovered that IL-6 is a potent inducer of miR-139 expression in OA chondrocytes. These findings indicate that miR-139 functions as a post-transcriptional regulator of MCPIP1 expression and enhances IL-6 expression, which further upregulates miR-139 expression in OA chondrocytes. These results support our hypothesis that miR-139-mediated downregulation of MCPIP1 promotes IL-6 expression in OA. Therefore, targeting miR-139 could be therapeutically beneficial in the management of OA.
Insights
MicroRNA-139 (miR-139) promotes osteoarthritis by downregulating MCPIP1, increasing inflammatory IL-6. Targeting miR-139 may offer a new therapeutic strategy for osteoarthritis management.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Osteoarthritis (OA) pathogenesis involves interleukin-6 (IL-6) overexpression.
- MCPIP1 regulates IL-6 expression post-transcriptionally.
- The 3' untranslated region (UTR) of MCPIP1 mRNA contains a miR-139 binding site.
Purpose of the Study:
- To investigate the post-transcriptional regulation of MCPIP1 by miR-139.
- To determine the impact of miR-139 on IL-6 expression in OA chondrocytes.
- To explore the therapeutic potential of targeting miR-139 in OA.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure gene and microRNA expression.
- Western blotting to assess protein levels.
- Luciferase reporter assays to confirm direct interaction between miR-139 and MCPIP1 3' UTR.
- Cell viability and apoptosis assays.
Main Results:
- miR-139 expression was elevated in OA cartilage and induced by IL-1β.
- Inhibition of miR-139 decreased IL-6 mRNA and protein levels, while overexpression increased them.
- miR-139 directly targeted MCPIP1 mRNA, reducing MCPIP1 expression.
- Overexpression of miR-139 promoted catabolic gene expression, induced apoptosis, and increased IL-6 levels, which in turn upregulated miR-139.
Conclusions:
- miR-139 acts as a post-transcriptional regulator of MCPIP1, enhancing IL-6 expression in OA chondrocytes.
- The miR-139/MCPIP1/IL-6 axis plays a crucial role in OA pathogenesis.
- Targeting miR-139 represents a potential therapeutic strategy for managing osteoarthritis.
Related Concept Videos
MicroRNAs
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

